title: Effect of bedside shielding on air-kerma rates around gynecologic intracavitary brachytherapy patients containing 226Ra or 137Cs.
abstract: An anthropomorphic phantom was implanted with 226Ra or 137Cs gynecologic intracavitary brachytherapy sources. Air-kerma rate measurements were taken at 10-cm increments along a horizontal plane from the side of the bed at 50 cm, 87 cm, and 136 cm heights above the floor. Five portable lead shields were placed at the head, at the foot and along one side of the bed and readings were taken again at the corresponding heights above, below and behind the shields. The readings were normalized to 100-mg Ra equivalence, and air-kerma rate curves were drawn allowing for the comparison of 226Ra and 137Cs with and without lead shields. The data demonstrated that the air-kerma rates for 137Cs were reduced more than those for 226Ra with the use of the portable lead shields. There was four times the transmission with 226Ra than with 137Cs. The optimal placement was with the lateral bedside shields proximal to the head and foot closest to the bed, with the middle shield overlapping in back. The shields at the head and foot should extend out and overlap the bedside shields. The level of the sources should be positioned near the bottom of the shields. This information will provide the medical health physicist with an estimate of air-kerma rates for both 226Ra and 137Cs with and without shielding for evaluating personnel exposures as well as the effectiveness of current shielding in relation to radiation protection requirements in adjacent rooms or hallways.
authors.affiliation: Department of Physics, San Diego State University, CA 92182.
authors.forename: P J
authors.initials: PJ
authors.lastname: Papin
authors.forename: M J
authors.initials: MJ
authors.lastname: Ramsey
authors.forename: R L
authors.initials: RL
authors.lastname: LaFontaine
authors.forename: R P
authors.initials: RP
authors.lastname: LePage
mesh_terms: D000390:Air Ionization; D001918:Brachytherapy; D002588:Cesium Radioisotopes / Q000627:therapeutic use*; D005260:Female; D005833:Genital Neoplasms, Female / Q000532:radiotherapy*; D006757:Hospital Units; D006801:Humans; D008961:Models, Structural; D011835:Radiation Protection; D011883:Radium / Q000627:therapeutic use*
chemical_list: D002588:Cesium Radioisotopes; D011883:Radium